JPRN-jRCT2080224837终止3 期
A combination study on WP-1303 or placebo and latanoprost ophthalmic solution in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OH).
适应症
试验速览
- 阶段
- 3 期
- 状态
- 终止
- 入组人数
- 280
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with POAG or OH.
- •IOP is less than 35 mmHg for both eyes.
- •IOP aftre latanoplost treated is greater than or equal to 18mmHg.
排除标准
- •Patients who have visual acuity of less than 0.3.
- •Presence of active eye disease (eg., uveitis, ocular infection, severe dry eye).
- •Pregnant women, lactating women or women who desire to be pregnant.
- •Patients who is judged inappropriate to participate in the study by investigator or sub-investigator.
研究者
相似试验
终止
3 期
WP-1303 Phase 3 combination studyprimary open-angle glaucoma, ocular hypertensionJPRN-jRCT2080224839Wakamoto pharmaceutical Co., Ltd.180
已完成
不适用
A phase III placebo-controlled comparative study of SJP-0118 in patients with bacterial conjunctivitisbacterial conjunctivitisJPRN-UMIN000027039Senju Pharmaceutical Co., Ltd.640
进行中（未招募）
不适用
Randomised phase 3B study on comparison of 2 treatment schedules with peginterferon alpha 2b and ribavirin short term versus standard term schedules in patients with chronic hepatitis C, genotype 2 or 3 and early virologic response comparison of efficacy, tolerability, quality of life and costs. - NDEUCTR2007-000279-40-ITA.S.L. 2
尚未招募
3 期
A Study of JNJ-56021927 Plus AndrogenDeprivation Therapy (ADT) Versus ADT inParticipants with Low-Volume mHSPCProstatic NeoplasmMlignant Neoplasm of ProstateC04.588.945.440.770Prostate CancerRBR-6txnfvFundação Pio XII - Hospital de Câncer de Barretos
已完成
不适用
urasidone HCl A Phase 3 Study of Patients With Acute SchizophreniaPER-052-08DAINIPPON SUMITOMO PHARMA AMERICA, INC,